|Table of Contents|

Disease burden of renal cancer attributable to high BMI in China from 1990 to 2019

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 11
Page:
2110-2115
Research Field:
Publishing date:

Info

Title:
Disease burden of renal cancer attributable to high BMI in China from 1990 to 2019
Author(s):
AN Yu1; CHEN Yarui1; LI Yanting1; LAI Min1; ZHANG Miaomiao1; YUAN Wenzhen2
1.The First School of Clinical Medicine of Lanzhou University,Gansu Lanzhou 730000,China;2.Department of Oncology Surgery,the First Hospital of Lanzhou University,Gansu Lanzhou 730000,China.
Keywords:
high body mass index; renal cancer; disease burden; disability adjusted life year; Joinpoint regression
PACS:
R737.11
DOI:
10.3969/j.issn.1672-4992.2023.11.025
Abstract:
Objective：To describe and analyze the variation tendency of renal cancer burden attributed to high body mass index（BMI） in China from 1990 to 2019.Methods:Partial data were obtained from the Global Burden of Disease Study 2019(GBD2019),the indicators such as mortality,disability adjusted life year(DALY),years of life lost(YLL),years lived with disability(YLD) and their age-standardized rates attributed to high BMI in the renal cancer population in the past thirty years were recorded by gender,age and year.The Joinpoint regression model was used to calculate the average annual percentage change(AAPC) reflecting the burden of renel cancer disease attributable to high BMI and its changing trend in China versus the global and different socio-demographic index(SDI) regions.Results:From 1990 to 2019,the standardized mortality rate of renal cancer due to high BMI in China increased from 0.03/100 000 to 0.13/100 000,and the standardized DALY rate increased from 0.86/100 000 to 3.45/100 000,with growth rates of 333% and 301% respectively.With the increase of age,the mortality rate,DALY rate,YLL rate and YLD rate all increased obviously.In the proportion of DALY rate,the YLD rate value was lower than the YLL rate,but its growth rate was faster than YLL rate.The increasing trends of attributed standardized mortality and DALY rates were significantly higher in China than globally and different SDI regions,with AAPC reaching 4.8% and 4.9%,respectively(both P<0.05),and the growth rate of male was more significant than that of female in China.Conclusion:From 1990 to 2019,the burden of renal cancer due to high BMI in China increased progressively and kept on rising,with the premature death led to a larger disease burden，and the burden of disability increased rapidly,especially in male and the elderly.Therefore,actively controlling obesity/overweight,strengthening early screening of renal cancer,focusing on rehabilitation guidance and health intervention have become important measures to reduce the disease burden.

References:

[1］PADALA SA,BARSOUK A,THANDRA KC,et al.Epidemiology of renal cell carcinoma［J］.World J Oncol,2020,11(3):79-87.
[2］GBD 2019 Diseases and Injuries Collaborators.Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019 ［J］.Lancet,2020,396(10258):1204-1222.
[3］BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries ［J］.CA Cancer J Clin,2018,68(6):394-424.
[4］CHEN W,ZHENG R,BAADE PD,et al.Cancer statistics in China,2015［J］.CA Cancer J Clin,2016,66(2):115-132.
[5］SIMS JN,YEDJOU CG,ABUGRI D,et al.Racial disparities and preventive measures to renal cell carcinoma［J］.Int J Environ Res Public Health,2018,15(6):1089.
[6］ZI H,HE SH,LENG XY,et al.Global,regional,and national burden of kidney,bladder,and prostate cancers and their attributable risk factors,1990-2019 ［J］.Mil Med Res,2021,8(1):1-15.
[7］国家卫生健康委员会.中国居民营养与慢性病状况报告(2020年)［J］.营养学报,2020,42(6):521. National Health Commission.Report on nutrition and chronic diseases of residents in China(2020)［J］.Acta Nutrimenta Sinica,2020,42(6):521.
[8］LIU X,SUN Q,HOU H,et al.The association between BMI and kidney cancer risk:An updated dose-response meta-analysis in accordance with PRISMA guideline ［J］.Medicine(Baltimore),2018,97(44):e12860.
[9］GBD 2019 Viewpoint Collaborators.Five insights from the Global Burden of Disease study 2019［J］.Lancet,2020,396(10258):1135-1159.
[10］ZHOU M,WANG H,ZENG X,et al.Mortality,morbidity,and risk factors in China and its provinces,1990-2017:a systematic analysis for the Global Burden of Disease Study 2017 ［J］.Lancet,2019,394(10204):1145-1158.
[11］KOCARNIK JM,COMPTON K,DEAN FE,et al.Cancer incidence,mortality,years of life lost,years lived with disability and disability-adjusted life years for 29 cancer groups from 2010 to 2019:A systematic snalysis for the Global Burden of Disease study 2019 ［J］.JAMA Oncol,2022,8(3):420-444.
[12］LI H Z,DU LB.Application of Joinpoint regression model in cancer epidemiological time trend analysis［J］.Chinese Journal of Preventive Medicine,2020,54(8):908-912.
[13］CHEN W,XIA C,ZHENG R,et al.Disparities by province,age,and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China:a comparative risk assessment ［J］.The Lancet Global Health,2019,7(2):e257-e269.
[14］MOHAMMADIAN M,PAKZAD R,TOWHIDI F,et al.Incidence and mortality of kidney cancer and its relationship with HDI(human development index) in the world in 2012 ［J］.Clujul Med,2017,90(3):286-293.
[15］MANCINI M,RIGHETTO M,BAGGIO G.Gender-related approach to kidney cancer management:Moving forward ［J］.Int J Mol Sci,2020,21(9):3378.
[16］项鑫,王乙.中国人口老龄化现状、特点、原因及对策［J］.中国老年学杂志,2021,41(18):4149-4152. XIANG X,WANG Y.The current situation,characteristics,causes and countermeasures of population aging in China ［J］.Chinese Journal of Gerontology,2021,41(18):4149-4152.
[17］LIU X,YU Y,WANG M,et al.Age-period-cohort analysis of kidney cancer deaths attributable to high body-mass index in China and U.S.adults ［J］.BMC Public Health,2020,20(1):882.
[18］ZHI X,KUANG XH,LIU K,et al.The global burden and temporal trend of cancer attributable to high body mass index:Estimates from the Global Burden of Disease Study 2019 ［J］.Front Nutr,2022,9:918330.
[19］吴瑞君,薛琪薪,罗志华.我国人口迁移和城镇化格局的转折性变化：2000-2020年［J］.上海行政学院学报,2022,23(01):74-86. WU RJ,XUE QX,LUO ZH.Turning changes in population migration and urbanization pattern in China:2000-2020［J］.The Journal of Shanghai Administration Institute,2022,23(01):74-86.
[20］WILDMAN RP,GU D,MUNTNER P,et al.Trends in overweight and obesity in Chinese adults:between 1991 and 1999-2000 ［J］.Obesity(Silver Spring),2008,16(6):1448-1453.
[21］WANG L,ZHOU B,ZHAO Z,et al.Body-mass index and obesity in urban and rural China:findings from consecutive nationally representative surveys during 2004-2018 ［J］.Lancet,2021,398(10294):53-63.
[22］MI YJ,ZHANG B,WANG HJ,et al.Prevalence and secular trends in obesity among Chinese adults,1991-2011 ［J］.Am J Prev Med,2015,49(5):661-669.

Memo

Memo:
-
Last Update: 2023-04-28